← Leaderboards
Timothy D. Read
Institute For Genomic Research
$8,710,197
Attributed
$19,369,374
Total exposure
10
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,369,374 · 10
By mechanism
R01$12,638,025 · 3
R44$3,000,000 · 1
R43$1,474,046 · 2
R21$897,789 · 2
R56$739,759 · 1
U01$619,755 · 1
Top collaborators
- Deborah Anne Dean23 shared
- Richard F Selden12 shared
- Sarah W Satola2 shared
Others in their field
Top investigators on “Genomics”
- Eric S Lander · Whitehead Institute For Biomedical Res$790,826,794
- Richard A Gibbs · Baylor College Of Medicine$661,700,875
- Richard K. Wilson · Washington University$497,388,134
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- David Heimbrook · Leidos Biomedical Research, Inc.$333,649,126
- Stacey Gabriel · Massachusetts Institute Of Technology$331,896,891
Research focus
GenomicsDesignInfectionPathogenChlamydia TrachomatisSamplingOrganismDiagnosticGenomeBaseGeneticTransmission ProcessDetectionAntibioticsSexually Transmitted DiseasesLifeGenome SequencingVaginaInnovationMedicalLeadFuturePelvic Inflammatory DiseaseEctopic Pregnancy
Grant awards (27)
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA$795,885
R01 · FY2025 · AI
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA$798,995
R01 · FY2024 · AI
Natural History of C. trachomatis urogenital and rectal infections$783,622
R01 · FY2024 · AI
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA$798,995
R01 · FY2023 · AI
Natural History of C. trachomatis urogenital and rectal infections$795,388
R01 · FY2023 · AI
Natural History of C. trachomatis urogenital and rectal infections$800,015
R01 · FY2022 · AI
Impact of ocular microbiome, immune response and Chlamydiae on trachoma following MDA$796,353
R01 · FY2022 · AI
Natural History of C. trachomatis urogenital and rectal infections$800,761
R01 · FY2021 · AI
Natural History of C. trachomatis urogenital and rectal infections$816,577
R01 · FY2020 · AI
C. trachomatis within-host genomic diversity and transmission between female anatomic sites$207,016
R21 · FY2020 · AI · contact PI
C. trachomatis within-host genomic diversity and transmission between female anatomic sites$261,773
R21 · FY2019 · AI · contact PI
Genomics-based prediction of antibiotic failure in S. aureus infections$195,000
R21 · FY2017 · AI · contact PI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,044,525
R01 · FY2016 · AI
Genomics-based prediction of antibiotic failure in S. aureus infections$234,000
R21 · FY2016 · AI · contact PI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,058,086
R01 · FY2015 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,071,188
R01 · FY2014 · AI
A Rapid Point-of-care Diagnostic for C. trachomatis STDs$1,000,000
R44 · FY2014 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,030,900
R01 · FY2013 · AI
A Rapid Point-of-care Diagnostic for C. trachomatis STDs$1,000,000
R44 · FY2013 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens$1,246,735
R01 · FY2012 · AI
A Rapid Point-of-care Diagnostic for C. trachomatis STDs$1,000,000
R44 · FY2012 · AI
A Rapid Point-of-care Diagnostic for Neisseria gonorrhoeae STDs$294,001
R43 · FY2012 · AI
Genetics of vancomycin intermediate resistance in S. aureus$739,759
R56 · FY2011 · AI · contact PI
A Rapid Point-of-care Diagnostic for Neisseria gonorrhoeae STDs$300,000
R43 · FY2011 · AI
A Rapid Point-of-care Diagnostic for C.trachomitis STDs$430,463
R43 · FY2010 · AI
A Rapid Point-of-care Diagnostic for C.trachomitis STDs$449,582
R43 · FY2009 · AI
THE WHOLE GENOME SEQUENCE OF ACTINOMYCES NAESLUNDI$619,755
U01 · FY2001 · DE